Observational Study on Patients With Hepatocellular Carcinoma (HCC)

Observational Study on Patients With Hepatocellular Carcinoma (HCC)

This is an ongoing, longitudinal, single centre, observational, retro-prospective clinical cohort study of patients with HCC in usual clinical practice. All the HCC patients diagnosed and treated in Liver Cancer Center, Nanfang Hospital are consecutively collected and followed up.

Inclusion Criteria:

• Clinical diagnosis of HCC;
• Age ≥ 16 years;
• Received treatment targeting for HCC at least once, including operation, ablation, TACE, sorafenib, radiotherapy, chemotherapy, etc;
• Good compliance with clinical treatment.

Exclusion Criteria:

• Diagnosed as other pathological types such as cholangiocarcinoma, or mixed liver cancer;
• Received only traditional Chinese medicine or symptomatic supportive treatment; (3) survival time ≤ 7 days;
• HCC diagnosed after liver transplantation;
• Poor compliance or important data deficient.